Cefpodoxime 100 mg + Clavulanic Acid 62.50mg with Water
Double-strength version of PODROCK™ CV — Cefpodoxime 100mg + Clavulanic Acid 62.5mg per 5mL. Same dual mechanism (PBP-binding cephalosporin + beta-lactamase inhibitor) at twice the concentration, designed for older paediatric patients above 20 kg where the standard CV suspension would require excessive volumes.
Same as PODROCK™ CV but for children 20–40 kg (4–12 years). High-dose cefpodoxime-clavulanate for severe recurrent otitis media, complicated sinusitis, community-acquired pneumonia and treatment-failure infections in older children.
Dosage and administration should be as prescribed by a qualified doctor or medical professional. Do not self-medicate. Always follow your physician's instructions regarding dose, frequency and duration of treatment.
PODROCK™ CV DS completes the highest-intensity level of the PODROCK™ paediatric range — providing the full treatment escalation pathway from plain cefpodoxime drops for simple infant infections through to beta-lactamase-protected double-strength suspension for complicated infections in older children. This complete range gives Seclis Labs franchise partners a portfolio that keeps prescribers within a single brand across every level of infection severity.
Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.